Target intelligence / Profile preview

Amyloid beta A4 precursor protein-binding family A member 3 (APBA3)

Target
APBA3
Molecular classification
Adapter protein, Scaffold protein, Phosphotyrosine-binding domain (PTB)-containing protein, Member of X11 family (X11/Mint family)
01

Overview

Amyloid beta A4 precursor protein-binding family A member 3 (APBA3) is an adapter protein of the X11/Mint family that interacts with the cytoplasmic domain of the Alzheimer’s disease amyloid precursor protein (APP) and plays important roles in signal transduction, cellular metabolism, and inflammation. In macrophages, APBA3 (also known as Mint3) binds and sequesters FIH-1, leading to enhanced HIF-1 activity under normoxic conditions, promoting glycolytic ATP production and supporting energy-intensive immune functions such as cytokine production and chemotaxis. APBA3 thereby acts as a nodal mediator linking metabolic regulation with immune responses and cell motility. It is implicated both in neurodegenerative conditions (Alzheimer’s disease) and cancer progression, and is regarded as a potential therapeutic target for modulating aberrant macrophage activity in diseases involving inflammation and metastasis.

Other names
MINT3X11L2Mint-3X11gammaAdapter protein X11gammaNeuron-specific X11L2 proteinNeuronal Munc18-1-interacting protein 3X11-like 2MGC:15815amyloid-beta A4 precursor protein-binding family A member 3X11-like 2 proteinPTB-bearing proteinamyloid beta (A4) precursor protein-binding, family A, member 3 (X11-like 2)mint3amyloid beta precursor protein binding family A member 3lin-10
02

Mechanism of action

Inhibits factor inhibiting HIF-1 (FIH-1) to enhance HIF-1 activity in macrophages; Modulates processing and binding of amyloid precursor protein (APP)

03

Biological functions

Signal transductionModulation of amyloid precursor protein (APP) processingEnhancement of hypoxia-inducible factor 1 (HIF-1) activity in macrophagesRegulation of cellular metabolismRegulation of inflammationControl of cell motility and microenvironment modulation
04

Disease associations

Neurodegenerative disease (candidate gene for Alzheimer’s disease)Cancer (role in inflammation and tumor metastasis)Other (sepsis, control of macrophage function)
05

Safety considerations

Targeting APBA3 may affect basic macrophage function and energy metabolism, with potential implications for immune response and tissue homeostasis

Beyond the preview

Go deeper on Amyloid beta A4 precursor protein-binding family A member 3 (APBA3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid beta A4 precursor protein-binding family A member 3 (APBA3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call